Cannabis Stocks Watchlist: Aurora Cannabis Soars High

Marijuana stocks rose Tuesday after President Trump said his administration would cooperate in the transition to Joe Biden’s presidency.

Cannabis sector-related exchange-traded funds were also increasing due to favoring a Biden presidency that could push the country toward legalizing sales of recreational marijuana.

For more in-depth coverage of the cannabis sector including buy and sell recommendations and investment strategies, follow Debra Borchardt on Real Money.

Here is a list of the cannabis stocks to watch and their performance this past week by the percentage change at the close of trading on Nov. 27.

Abbvie Inc | Increased +0.71% | Price $104.98

Last month. AbbVie  (ABBV) – Get Report posted stronger-than-expected third-quarter earnings as strong global sales from its popular Humira rheumatoid arthritis treatment as well as strong cancer-drug sales offset a dip in revenue related to its Botox treatments.

AbbVie said net earnings for the three months ended in September were $2.31 billion, or $1.29 a share, vs. $1.88 billion, or $1.26 a share, in the comparable year-earlier quarter.

TheStreet Quant Ratings rates Abbvie Inc as a Buy with a rating score of A-.

Aurora Cannabis Inc | Increased +25.64% | Price $8.92

Earlier this month, Aurora Cannabis  (ACB) – Get Report shares slumped after the marijuana producer launched an offering of units and Stifel analyst W. Andrew Carter downgraded the stock to sell from hold.

He raised his share-price rating to C$6.50 (US$4.96) from C$3.50 (US$2.67) based on valuation.

Source Article